Recall archive / FDA device enforcement
HA FlexTrak-Patient transport functionality to transport the patient from the preparation area to the MR system, Prod... — FDA record Z-1949-2024
Reported ongoing
Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.
Source date May 3, 2024. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.
Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.
What the record says
- Product
- HA FlexTrak-Patient transport functionality to transport the patient from the preparation area to the MR system, Product Number: 989710006412
- Reason
- Oil may leak from the HA FlexTrack Trolley onto the floor when pressing the hydraulic pedal, resulting in a potential slipping/falling hazard
- Classification
- Class II
- Recalling firm
- Philips North America Llc
- Quantity
- 100 units
- Agency-reported status
- Ongoing
- Source record identifier
- Z-1949-2024
What the recall classes mean. Classification is an agency assessment, not individual medical advice.
Lot and product identifiers
| Label field | Details supplied by the agency |
|---|---|
| Lot, code or applicability | UDI: (01)00884838099470(21) Serial Numbers: 1538 1539 1540 1541 1542 1543 1544 1545 1546 1548 1550 1552 1553 1554 1556 1557 1558 1559 1560 1561 1563 1564 1565 1566 1567 1568 1569 1634 1635 1636 1637 1638 1639 1640 1641 1642 1643 1644 1646 1647 1648 1649 1669 1670 1672 1673 1674 1675 1676 1677 1678 1679 1680 1681 1682 101747 101749 101750 101751 101753 101754 101756 101757 101758 101759 101762 101779 101780 101781 101782 101783 101784 101785 101787 101789 101790 101791 101792 101793 101794 101795 101797 101798 101799 101800 101801 101802 101803 101804 101806 101807 101809 101810 101811 101812 101813 101814 101850 101851 SN101852 |
Match all identifying details in the current notice. A brand name alone is not enough.
Distribution
Worldwide distribution - US Nationwide and the countries of Australia, Austria, Bahrain, Bangladesh, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Estonia, Fiji, Finland, France, French Guiana, Germany, Guadeloupe, Honduras, Hong Kong, India, Indonesia, Ireland, Italy, Japan, Jordan, Lithuania, Martinique, Mexico, Morocco, Netherlands, Norway, Oman, Peru, Poland, Russian Fed., Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Taiwan, Thailand, United Kingdom.
States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.
- Alaska
- Alabama
- Arkansas
- Arizona
- California
- Colorado
- Connecticut
- Delaware
- Florida
- Georgia
- Hawaii
- Iowa
- Idaho
- Illinois
- Indiana
- Kansas
- Kentucky
- Louisiana
- Massachusetts
- Maryland
- Maine
- Michigan
- Minnesota
- Missouri
- Mississippi
- Montana
- North Carolina
- North Dakota
- Nebraska
- New Hampshire
- New Jersey
- New Mexico
- Nevada
- New York
- Ohio
- Oklahoma
- Oregon
- Pennsylvania
- Rhode Island
- South Carolina
- South Dakota
- Tennessee
- Texas
- Utah
- Virginia
- Vermont
- Washington
- Wisconsin
- West Virginia
- Wyoming
Dates in the source
- Report date
- Jun 12, 2024
- Recall initiation date
- May 3, 2024
- Center classification date
- Jun 4, 2024
FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.